Login
Navigate Fool.com
Will TZYM beat
the market?
Community Rating: 2 Stars: Unattractive

0.00 0.00 (0.00%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $0.00
Previous Close $0.00
Daily Range $0.00 - $0.00
52-Week Range $0.00 - $0.00
Market Cap $0.00
P/E Ratio 0.00
Dividend (Yield) $0.00 (0.0%)
Volume 0
Average Daily Volume 0
Current FY EPS -$0.17

How do you think TZYM
will perform against the market?

Top TZYM Bull/Bear Pitches

 

There are no pitches that meet the Top Bull criteria. Explain

If this upsets you, start recommending pitches here!

 

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches here!

News & Commentary

This Week in Biotech: Part 2

A look at the biggest stories in biotech this week and what they mean for investors.

After-Hours Earnings Report for March 28, 2013 : PCTI, TZYM, AUXO, ILIU

After-Hours Earnings Report for March 28, 2013 : PCTI, TZYM, AUXO, ILIU

3 Big Biotech Trial Results

Insights into today's binary events

The Nasdaq Now: Tranzyme Collapses After Drug Trial Failure

NetApp and Zynga were up on the day.

Massive Meltdown for This Biotech

Tranzyme's disappointing phase 3 study causes a massive meltdown for the stock.

U.S. HOT STOCK FUTURES: HOT STOCKS TO WATCH

Is it Time for us to Invest in these Medical Companies as Well?

Tranzyme Investors: Why Shares Just Got Halved

Tranzyme's ulimorelin fails as placebo performs better than expected.

24/7 Wall St. Closing Bell (TWX, DIS, PEP, KBH, FSLR, PLOW, FCEL, NNBR, VELT, HTH, ODC, MIDD, TODU,

24/7 Wall St. Closing Bell (TWX, DIS, PEP, KBH, FSLR, PLOW, FCEL, NNBR, VELT, HTH, ODC, MIDD, TODU, PCBC, ANTH, TZYM, CDTI)

Tranzyme: Assessing The Implosion & Prospects Ahead (TZYM)

See More TZYM News...

Sector

Healthcare

Industry

Drugs

OCERA THERAPEUTICS, INC. (TZYM) Description

OCERA THERAPEUTICS, INC. Website: http://www.tranzyme.com/

Featured Broker Partners

Learn more about our new Fool ticker page!

Take a Tour
no thanks